358 related articles for article (PubMed ID: 33362382)
1. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
Ishida N; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Osawa S; Hamaya Y; Shinmura K; Sugimura H; Miura K; Furuta T; Sugimoto K
World J Gastroenterol; 2020 Dec; 26(45):7263-7271. PubMed ID: 33362382
[TBL] [Abstract][Full Text] [Related]
2. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
3. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
[TBL] [Abstract][Full Text] [Related]
4. [A Rare Case of Primary Splenic Malignant Lymphoma Associated with Esophagogastric Junction Neuroendocrine Carcinoma(NEC)].
Fujita R; Ono HA; Tsuura Y; Yakeishi M; Kobayashi K; Daibo S; Sakai J; Suwa H; Minami Y; Nojiri K; Yosida K; Mogaki M; Masui H; Nagahori K
Gan To Kagaku Ryoho; 2022 Feb; 49(2):208-210. PubMed ID: 35249063
[TBL] [Abstract][Full Text] [Related]
5. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel.
Matsubara Y; Ando T; Hosokawa A; Mihara H; Takagi H; Nakata N; Yoshita H; Nanjo S; Kajiura S; Fujinami H; Sugiyama T
Intern Med; 2018 Mar; 57(5):671-675. PubMed ID: 29151523
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.
Arva NC; Pappas JG; Bhatla T; Raetz EA; Macari M; Ginsburg HB; Hajdu CH
Am J Surg Pathol; 2012 Jan; 36(1):149-53. PubMed ID: 22173120
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Gastric Neuroendocrine Carcinoma with Bulky Lymph Node Metastases, Solitary Liver Metastasis, and Left Adrenal Metastasis Curatively Resected after Chemotherapy].
Tsukamoto T; Togano S; Edagawa E; Kaizaki R; Hori T; Takatsuka S
Gan To Kagaku Ryoho; 2019 Jan; 46(1):103-105. PubMed ID: 30765655
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa.
Kolin DL; Duan K; Ngan B; Gerstle JT; Krzyzanowska MK; Somers GR; Mete O
Endocr Pathol; 2018 Mar; 29(1):21-26. PubMed ID: 28733877
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
16. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
[TBL] [Abstract][Full Text] [Related]
17. [Case of Unresectable Gastric Mixed Neuroendocrine Neoplasm(MiNEN)Treated with Chemotherapy].
Suemori K; Uno F; Hisamatsu K; Mizuno D; Miyauchi S; Iga N; Yoshida R; Kawai H; Ishizaki M; Nishi H
Gan To Kagaku Ryoho; 2022 Jan; 49(1):59-61. PubMed ID: 35046363
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes.
Evans LM; Geenen KR; O'Shea A; Hedgire SS; Ferrone CR; Thiele EA
Am J Med Genet A; 2022 Sep; 188(9):2666-2671. PubMed ID: 35612824
[TBL] [Abstract][Full Text] [Related]
19. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
20. Gastric neuroendocrine carcinoma staged and followed with (18)F-FDG PET/CT--a report of 3 cases.
Makis W; Ciarallo A; Hickeson M; Derbekyan V; Novales-Diaz JA; Lisbona R
Clin Nucl Med; 2013 Jun; 38(6):447-50. PubMed ID: 23640237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
